Renee Lentini Immuno Gen, Inc. (IMGN) insider trading activity

Renee Lentini is VP & PRIN ACCTG OFFICER of ImmunoGen, Inc.. Currently has a direct ownership of 0 shares of IMGN, which is worth approximately $0. The most recent transaction as insider was on Feb 12, 2024, when has been sold 14,723 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Renee Lentini Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 12 2024	SELL Sale (or disposition) back to the issuer	-	14,723 Reduced 100.0%	0 Common Stock
Feb 05 2024	SELL Open market or private sale	$77,088 $29.3 p/Share	2,631 Reduced 15.16%	14,723 Common Stock
Feb 02 2024	BUY Exercise of conversion of derivative security	-	8,435 Added 32.71%	17,354 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	$7,476 $16.01 p/Share	467 Added 4.98%	8,919 Common Stock
Dec 26 2023	SELL Open market or private sale	$194,737 $29.74 p/Share	6,548 Reduced 43.65%	8,452 Common Stock
Dec 22 2023	BUY Exercise of conversion of derivative security	-	15,000 Added 50.0%	15,000 Common Stock
Nov 06 2023	SELL Open market or private sale	$3,356,843 $15.29 p/Share	219,545 Reduced 100.0%	0 Common Stock
Nov 06 2023	BUY Exercise of conversion of derivative security	$849,722 $7.05 p/Share	120,528 Added 35.44%	219,545 Common Stock
Sep 12 2023	BUY Exercise of conversion of derivative security	$107,603 $4.28 p/Share	25,141 Added 20.25%	99,017 Common Stock
Aug 03 2023	BUY Exercise of conversion of derivative security	$127,072 $2.49 p/Share	51,033 Added 40.86%	73,876 Common Stock
Aug 02 2023	SELL Open market or private sale	$2,602,261 $17.55 p/Share	148,277 Reduced 86.65%	22,843 Common Stock
Aug 02 2023	BUY Exercise of conversion of derivative security	$723,591 $4.88 p/Share	148,277 Added 46.42%	171,120 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	$12,939 $4.05 p/Share	3,195 Added 12.27%	22,843 Common Stock
Dec 30 2022	BUY Grant, award, or other acquisition	$5,295 $3.92 p/Share	1,351 Added 6.43%	19,648 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	$9,609 $3.83 p/Share	2,509 Added 12.06%	18,297 Common Stock
Dec 31 2021	BUY Grant, award, or other acquisition	$10,959 $5.6 p/Share	1,957 Added 11.03%	15,788 Common Stock
Jun 30 2021	BUY Grant, award, or other acquisition	$9,290 $5.52 p/Share	1,683 Added 10.85%	13,831 Common Stock

Renee Lentini

VP & PRIN ACCTG OFFICER

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMGN shares.

Notify only if

Value

Insider Trading

Get notified when an Immuno Gen, Inc. insider buys or sells IMGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to ImmunoGen, Inc.

Track Activities on IMGN

Account